VATS lobectomy improves overall survival vs open surgery in early-stage NSCLC
Does a less invasive lung cancer surgery help people live longer? New analysis says yes.
An individual patient data meta-analysis of 3 RCTs (n=1185) found VATS lobectomy for early-stage NSCLC was associated with a 21% mortality r…
A new analysis of nearly 1,200 patients shows less invasive lung surgery lowers the risk of death by 21% compared to traditional open surger…
Phase 2 Study: L-SABR Plus Standard Therapy in Metastatic NSCLC Patients
Could Targeted Radiation Therapy Offer Hope for Lung Cancer Patients?
This Phase 2 trial evaluates the addition of liver stereotactic ablative radiotherapy (L-SABR) to standard drug therapy in metastatic NSCLC.…
A new trial tests if adding targeted liver radiation to standard drugs helps metastatic lung cancer patients live longer without disease pro…